摘要 |
<P>PROBLEM TO BE SOLVED: To provide an improved pharmaceutical composition treating to the problem of low solubility to aqueous solution of certain carbamic acid compounds (e.g., which inhibit HDAC (histone deacetylase) activity) (e.g., PXD-101, N-hydroxy-3-(3-phenylsulfamoyl-phenyl)-acrylamide). <P>SOLUTION: The pharmaceutical compositions comprise one or more additional ingredients selected from cyclodextrin, arginine, and meglumine. The present invention also pertains to the use of such compositions, for example, in the inhibition of HDAC, and in the treatment of conditions mediated by HDAC, cancer, proliferative conditions, psoriasis, etc. <P>COPYRIGHT: (C)2013,JPO&INPIT |